Ganglioside GM1 Lactone
Ganglioside GM1 Lactone Uses, Dosage, Side Effects, Food Interaction and all others data.
Ganglioside GM1 Lactone (Sygen, AGF 2) has been investigated for the treatment of Parkinson Disease. It is a naturally occurring substance in the nerve cell’s membrane that is thought to play a role in cell growth, development, and repair. Ganglioside GM1 Lactone completed phase 2 trials for parkinson's disease (PD) treatment. Sygen appears to be beneficial in patients with severe spinal cord injury. Treatment results in a 52% decrease in mortality 48 hours after the induction of ischemia in gerbils by permanent unilateral ligation of the common carotid artery.
| Trade Name | Ganglioside GM1 Lactone |
| Generic | Siagoside |
| Siagoside Other Names | Ganglioside GM1 lactone, Siagoside, Siagosido, Siagosidum |
| Type | |
| Formula | C73H129N3O30 |
| Weight | Average: 1528.826 Monoisotopic: 1527.866089766 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Ganglioside GM1 Lactone
